Mary Ashley Canevaro
| This email address is being protected from spambots. You need JavaScript enabled to view it.
Principal Investigator Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, produced by Neuren Pharmaceuticals, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).
Two researchers have been named Civitan Emerging Scholars for 2024-2025 by the Civitan International Research Center for neurodevelopmental disorders.
Heersink School of Medicine is proud to offer a few ways faculty can get more involved with initiatives, operations, and efforts in the school.
For Black History Month, the Heersink School of Medicine Office for Diversity and Inclusion sat down with a few employees and learners who are making a difference around UAB to hear why the commemorative month is important to them.
For Black History Month, the Heersink School of Medicine Office for Diversity and Inclusion sat down with a few employees and learners who are making a difference around UAB to hear why the commemorative month is important to them.